Table III.
Data associated with tumors
| Parameter | Without AL | AL | P-value | ||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Clinical stage: | 0.454 | ||||
| I | 8 | 30.8 | 2 | 12.5 | |
| II | 2 | 7.7 | 3 | 18.8 | |
| III | 16 | 61.5 | 11 | 68.7 | |
| IV | 0 | 0 | 0 | 0 | |
| Pathologic stage | 0.298 | ||||
| Complete response: | 4 | 15.4 | 1 | 6.3 | |
| I | 13 | 50.0 | 7 | 43.7 | |
| II | 3 | 11.5 | 2 | 12.5 | |
| III | 6 | 23.1 | 6 | 37.5 | |
| IV | 0 | 0 | 0 | 0 | |
| Grade: | 0.066 | ||||
| Well-differentiated | 7 | 26.9 | 0 | 0 | |
| Moderately differentiated | 19 | 73.1 | 15 | 93.7 | |
| Poorly differentiated | 0 | 0 | 1 | 6.3 | |
| Angioinvasion: | 0.352 | ||||
| Positive | 2 | 7.7 | 3 | 18.8 | |
| Negative | 24 | 92.3 | 13 | 81.2 | |
| Lympho-angioinvasive: | 1.000 | ||||
| Positive | 3 | 11.5 | 2 | 12.5 | |
| Negative | 23 | 88.5 | 14 | 87.5 | |
| Perineural invasion: | 0.352 | ||||
| Positive | 2 | 7.7 | 3 | 18.8 | |
| Negative | 24 | 92.3 | 13 | 81.2 | |